SHOULDER INNOVATIONS, INC. Diluted Shares Outstanding (Weighted Average)
SHOULDER INNOVATIONS, INC. (SI) reported Diluted Shares Outstanding (Weighted Average) of 20.74 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 20.74M shares, a 17780.99% increase year-over-year.
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 20.65M shares, a 22992.01% increase year-over-year.
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 20.73M shares, a 24575.54% increase year-over-year.
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 13.60M shares, a 22814.09% increase year-over-year.
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 8.67M shares, a 13340.49% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 64.53K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 20.74M shares 10-Q · filed 2026-08-06 | 20.69M shares 10-Q · filed 2026-08-06 | 20.71M shares derived: average of 3 quarters · filed 2026-08-06 | 18.93M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 20.65M shares 10-Q · filed 2026-05-13 | 20.69M shares derived: average of 2 quarters · filed 2026-05-13 | 18.33M shares derived: average of 3 quarters · filed 2026-05-13 | 13.78M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 20.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 17.17M shares derived: average of 2 quarters · filed 2026-03-10 | 11.48M shares derived: average of 3 quarters · filed 2026-08-06 | 8.67M shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 13.60M shares 10-Q · filed 2025-11-12 | 6.86M shares derived: average of 2 quarters · filed 2026-08-06 | 4.65M shares 10-Q · filed 2025-11-12 | 3.47M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 115.97K shares 10-Q · filed 2026-08-06 | 102.78K shares 10-Q · filed 2026-08-06 | 96.48K shares derived: average of 3 quarters · filed 2026-08-06 | 87.20K shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 89.44K shares 10-Q · filed 2026-05-13 | 86.73K shares derived: average of 2 quarters · filed 2026-05-13 | 77.61K shares derived: average of 3 quarters · filed 2026-05-13 | 72.55K shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 84.03K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 71.70K shares derived: average of 2 quarters · filed 2026-03-10 | 66.92K shares derived: average of 3 quarters · filed 2026-03-10 | 64.53K shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 59.37K shares 10-Q · filed 2025-11-12 | 58.36K shares derived: average of 2 quarters · filed 2025-11-12 | 58.03K shares 10-Q · filed 2025-11-12 | |
| 2024-06-30 | 57.35K shares 10-Q · filed 2025-09-09 | 57.35K shares 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |